157 related articles for article (PubMed ID: 23016859)
1. Immunoproteasome in cancer and neuropathologies: a new therapeutic target?
Bellavista E; Andreoli F; Parenti MD; Martucci M; Santoro A; Salvioli S; Capri M; Baruzzi A; Del Rio A; Franceschi C; Mishto M
Curr Pharm Des; 2013; 19(4):702-18. PubMed ID: 23016859
[TBL] [Abstract][Full Text] [Related]
2. New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells.
Kimura H; Caturegli P; Takahashi M; Suzuki K
J Immunol Res; 2015; 2015():541984. PubMed ID: 26636107
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of the immunoproteasome: current status and future directions.
Miller Z; Ao L; Kim KB; Lee W
Curr Pharm Des; 2013; 19(22):4140-51. PubMed ID: 23181576
[TBL] [Abstract][Full Text] [Related]
4. Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives.
Gan T; Li Y; Zhou XJ; Zhang H
Int J Biol Sci; 2020; 16(14):2518-2526. PubMed ID: 32792854
[TBL] [Abstract][Full Text] [Related]
5. The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer.
Tripathi SC; Vedpathak D; Ostrin EJ
Cells; 2021 Dec; 10(12):. PubMed ID: 34944095
[TBL] [Abstract][Full Text] [Related]
6. The Function of Immunoproteasomes-An Immunologists' Perspective.
van den Eshof BL; Medfai L; Nolfi E; Wawrzyniuk M; Sijts AJAM
Cells; 2021 Nov; 10(12):. PubMed ID: 34943869
[TBL] [Abstract][Full Text] [Related]
7. The immunoproteasome in antigen processing and other immunological functions.
Basler M; Kirk CJ; Groettrup M
Curr Opin Immunol; 2013 Feb; 25(1):74-80. PubMed ID: 23219269
[TBL] [Abstract][Full Text] [Related]
8. The immunoproteasome: a novel drug target for autoimmune diseases.
Basler M; Mundt S; Bitzer A; Schmidt C; Groettrup M
Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S74-9. PubMed ID: 26458097
[TBL] [Abstract][Full Text] [Related]
9. Immune and non-immune functions of the immunoproteasome.
Angeles A; Fung G; Luo H
Front Biosci (Landmark Ed); 2012 Jan; 17(5):1904-16. PubMed ID: 22201844
[TBL] [Abstract][Full Text] [Related]
10. The immunoproteasome: An old player with a novel and emerging role in alloimmunity.
Eskandari SK; Seelen MAJ; Lin G; Azzi JR
Am J Transplant; 2017 Dec; 17(12):3033-3039. PubMed ID: 28719024
[TBL] [Abstract][Full Text] [Related]
11. A patent review of immunoproteasome inhibitors.
Ogorevc E; Schiffrer ES; Sosič I; Gobec S
Expert Opin Ther Pat; 2018 Jul; 28(7):517-540. PubMed ID: 29865878
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic dynamics of human 20S thymoproteasome.
Kuckelkorn U; Stübler S; Textoris-Taube K; Kilian C; Niewienda A; Henklein P; Janek K; Stumpf MPH; Mishto M; Liepe J
J Biol Chem; 2019 May; 294(19):7740-7754. PubMed ID: 30914481
[TBL] [Abstract][Full Text] [Related]
13. The immunoproteasome: an emerging therapeutic target.
Lee W; Kim KB
Curr Top Med Chem; 2011 Dec; 11(23):2923-30. PubMed ID: 21824107
[TBL] [Abstract][Full Text] [Related]
14. The Immunoproteasome: An Emerging Target in Cancer and Autoimmune and Neurological Disorders.
Zerfas BL; Maresh ME; Trader DJ
J Med Chem; 2020 Mar; 63(5):1841-1858. PubMed ID: 31670954
[TBL] [Abstract][Full Text] [Related]
15. On the role of the immunoproteasome in transplant rejection.
Basler M; Li J; Groettrup M
Immunogenetics; 2019 Mar; 71(3):263-271. PubMed ID: 30220008
[TBL] [Abstract][Full Text] [Related]
16. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E
J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114
[TBL] [Abstract][Full Text] [Related]
17. A Sentinel in the Crosstalk Between the Nervous and Immune System: The (Immuno)-Proteasome.
Limanaqi F; Biagioni F; Gaglione A; Busceti CL; Fornai F
Front Immunol; 2019; 10():628. PubMed ID: 30984192
[TBL] [Abstract][Full Text] [Related]
18. Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome.
Bosc E; Nastri J; Lefort V; Valli M; Contiguiba F; Pioli R; Furlan M; Bolzani VDS; El Amri C; Reboud-Ravaux M
Biochem Biophys Res Commun; 2018 Feb; 496(3):961-966. PubMed ID: 29355526
[TBL] [Abstract][Full Text] [Related]
19. Targeting immunoproteasome in neurodegeneration: A glance to the future.
Tundo GR; Cascio P; Milardi D; Santoro AM; Graziani G; Lacal PM; Bocedi A; Oddone F; Parravano M; Coletta A; Coletta M; Sbardella D
Pharmacol Ther; 2023 Jan; 241():108329. PubMed ID: 36526014
[TBL] [Abstract][Full Text] [Related]
20. Immunoproteasome-specific inhibitors and their application.
Basler M; Groettrup M
Methods Mol Biol; 2012; 832():391-401. PubMed ID: 22350900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
